London, 5th August 2026 — EBM Newsdesk Analysis — By Anthony Gill
Sir Jim Ratcliffe’s Ineos and its shareholders have invested more than €400 million in listed chemical companies, making a contrarian bet that Europe’s battered chemicals sector is approaching a recovery after years of plant closures, weak demand and rising costs.
Ineos Quattro, one of the privately owned group’s main financing businesses, recently disclosed a €200 million investment in selected chemical shares. That followed an earlier €200 million purchase of publicly traded chemical equities, while Ineos’s three shareholders have reportedly invested additional funds alongside the company.
Join The European Business Briefing
New subscribers this quarter are entered into a draw to win a Rolex Submariner. Join 40,000+ founders, investors and executives who read EBM every day.
SubscribeThe purchases represent a striking vote of confidence from a group whose founder has repeatedly warned that the European chemical industry is facing extinction.
Buying Into Europe’s Industrial Crisis
European chemical producers have been damaged by high gas and electricity prices, carbon charges, ageing plants and competition from lower-cost facilities in China, the United States and the Middle East.
The collapse of Domo Chemicals demonstrated how quickly those pressures can overwhelm heavily indebted manufacturers. Its insolvency became another warning that Europe’s chemical industry is confronting a structural rather than temporary crisis.
Ratcliffe has argued that European producers are being priced as though their decline is irreversible. Ineos’s share purchases suggest it believes investors have become too pessimistic and that even a modest recovery in margins could produce substantial gains.
That position is not without logic. Chemical companies are deeply cyclical, meaning profits can recover rapidly when capacity closes, inventories fall or selling prices rise. Recent disruption around the Strait of Hormuz improved margins for some products by restricting regional supplies, temporarily easing pressure on European producers.
Yet the same geopolitical disruption also drove feedstock costs sharply higher. As EBM previously reported, the Iran conflict exposed how vulnerable European producers remain when oil and naphtha prices rise faster than chemical selling prices.
Creditors Question the Strategy
Ineos’s investment has attracted criticism from some creditors, who believe the cash should have been used to repurchase the company’s discounted bonds.
The group has approximately $19 billion of debt, accumulated through years of acquisitions and major industrial investments. Buying external equities while its own debt trades below face value may appear unnecessarily aggressive, particularly while the underlying chemicals market remains fragile.
Ineos has said it retains strong liquidity and follows a disciplined capital-allocation strategy that considers both investments and debt management.
The group is simultaneously completing Project ONE, its €5 billion ethane cracker in Antwerp. The plant is intended to be one of Europe’s most efficient petrochemical facilities and represents the continent’s largest new chemical investment in a generation.
However, new technology cannot eliminate every structural disadvantage. German manufacturers are already struggling with weak demand and logistical disruption as low Rhine water levels place additional pressure on industrial supply chains.
European companies also face mounting competition from subsidised and lower-cost Asian production, part of the broader industrial challenge created by China’s second export shock.
A Calculated Contrarian Bet
Ratcliffe’s wager is not necessarily a declaration that Europe’s chemical crisis has ended. It is a bet that share prices already reflect most of the damage.
The opportunity is clear: plant closures could reduce excess capacity, while any decline in European energy prices would improve margins. But the risks remain substantial. Cheap imports, carbon costs and expensive energy are not short-term problems.
Ineos may ultimately be proved right that Europe’s chemical champions have been undervalued. The more uncomfortable possibility is that they are cheap because the continent has still not addressed the policies driving its industrial decline.



































